Is HLA type a possible cancer risk modifier in Lynch syndrome?

Abstract:
No abstract specified

SEEK ID: https://publications.h-its.org/publications/1619

DOI: 10.1002/ijc.34312

Research Groups: Data Mining and Uncertainty Quantification

Publication type: Journal

Journal: International Journal of Cancer

Citation: Intl Journal of Cancer,ijc.34312

Date Published: 14th Oct 2022

Registered Mode: by DOI

Authors: Aysel Ahadova, Johannes Witt, Saskia Haupt, Richard Gallon, Robert Hüneburg, Jacob Nattermann, Sanne ten Broeke, Lena Bohaumilitzky, Alejandro Hernandez‐Sanchez, Mauro Santibanez‐Koref, Michael S. Jackson, Maarit Ahtiainen, Kirsi Pylvänäinen, Katarina Andini, Vince Kornel Grolmusz, Gabriela Möslein, Mev Dominguez‐Valentin, Pål Møller, Daniel Fürst, Rolf Sijmons, Gillian M. Borthwick, John Burn, Jukka‐Pekka Mecklin, Vincent Heuveline, Magnus von Knebel Doeberitz, Toni Seppälä, Matthias Kloor

help Submitter
Citation
Ahadova, A., Witt, J., Haupt, S., Gallon, R., Hüneburg, R., Nattermann, J., ten Broeke, S., Bohaumilitzky, L., Hernandez‐Sanchez, A., Santibanez‐Koref, M., Jackson, M. S., Ahtiainen, M., Pylvänäinen, K., Andini, K., Grolmusz, V. K., Möslein, G., Dominguez‐Valentin, M., Møller, P., Fürst, D., … Kloor, M. (2022). Is HLA type a possible cancer risk modifier in Lynch syndrome? In International Journal of Cancer (Vol. 152, Issue 10, pp. 2024–2031). Wiley. https://doi.org/10.1002/ijc.34312
Activity

Views: 1709

Created: 15th Feb 2023 at 14:24

Last updated: 5th Mar 2024 at 21:25

help Tags

This item has not yet been tagged.

help Attributions

None

Powered by
(v.1.14.2)
Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH